Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Crohn disease (CD) and ulcerative colitis (UC) are increasingly common, chronic forms of inflammatory bowel disease. The behavior of these diseases varies unpredictably among patients. Identification of reliable prognostic biomarkers would enable treatment to be personalized so that patients destined to experience aggressive disease could receive appropriately potent therapies from diagnosis, while those who will experience more indolent disease are not exposed to the risks and side effects of unnecessary immunosuppression. Using transcriptional profiling of circulating T cells isolated from patients with CD and UC, we identified analogous CD8+ T cell transcriptional signatures that divided patients into 2 otherwise indistinguishable subgroups. In both UC and CD, patients in these subgroups subsequently experienced very different disease courses. A substantially higher incidence of frequently relapsing disease was experienced by those patients in the subgroup defined by elevated expression of genes involved in antigen-dependent T cell responses, including signaling initiated by both IL-7 and TCR ligation - pathways previously associated with prognosis in unrelated autoimmune diseases. No equivalent correlation was observed with CD4+ T cell gene expression. This suggests that the course of otherwise distinct autoimmune and inflammatory conditions may be influenced by common pathways and identifies what we believe to be the first biomarker that can predict prognosis in both UC and CD from diagnosis, a major step toward personalized therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CTLs are emerging as major mediators of human IBD, which is also prognostically linked to CTL profiling.31”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Research works printed but not linked: 2
- Fagan, 1975, N Engl J Med., 293, 257
- Muller, 1998, Am J Pathol., 152, 261
Cited by
Items 101–200 of 305
Quinn, E. M., Coleman, C., Molloy, B., Castro, P. D., Cormican, P., Trimble, V., Mahmud, N. U., & McManus, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140049 · Cited by 43
Richard, A. C., Lyons, P., Peters, J. E., Biasci, D., Flint, S. M., Lee, J. C., McKinney, E. F., Siegel, R. M., & Smith, K. G. C. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-649 · Cited by 38
Self-citationCordero, R. Y., Cordero, J. B., Stiemke, A. B., Datta, L. W., Buyske, S. G., Kugathasan, S., McGovern, D. P. B., Brant, S. R., & Simpson, C. L. (2022) · Human Molecular Genetics · doi:10.1093/hmg/ddac269 · Cited by 42
Lichtenstein, G. R., & McGovern, D. P. B. (2016) · The American Journal of Gastroenterology Supplements · doi:10.1038/ajgs.2016.17 · Cited by 37
Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders
Velde, A. A. T., Bezema, T., van Kampen, A. H. C., Kraneveld, A. D., Hart, B. A. ‘., van Middendorp, H., Hack, E., van Montfrans, J. M., Belzer, C., Jans-Beken, L., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00587 · Cited by 41
T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases
McKinney, E. F., & Smith, K. G. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.81 · Cited by 36
Self-citationImmunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases
Selin, K., Hedin, C. R. H., & Villablanca, E. J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab085 · Cited by 39
Kalla, R., Adams, A. T., Ventham, N. T., Kennedy, N. A., White, R. F., Clarke, C., Ivens, A. C., Bergemalm, D., Vatn, S., López-Jimena, B., et al. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa134 · Cited by 36
Predicting the Individual Risk of Acute Severe Colitis at Diagnosis
Cesarini, M., Collins, P. G. S., Rönnblom, A., Santos, A., Wang, L. M., Sjöberg, D., Parkes, M., Keshav, S., & Travis, S. P. L. (2016) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjw159 · Cited by 38
Self-citationAssadsangabi, A., Evans, C. A., Corfe, B. M., & Lobo, A. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/1426954 · Cited by 39
Igalouzene, R., Hernández‐Vargas, H., Benech, N., Guyennon, A., Bauché, D., Barrachina, C., Dubois, E., Marie, J. C., & Soudja, S. M. (2022) · Journal of Clinical Investigation · doi:10.1172/jci151020 · Cited by 37
Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD
Yoon, S. M., Haritunians, T., Chhina, S., Liu, Z., Yang, S., Landers, C. J., Li, D., Ye, B. D., Shih, D. Q., Vasiliauskas, E. A., et al. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001150 · Cited by 37
Technological readiness and implementation of genomic‐driven precision medicine for complex diseases
Franks, P. W., Melén, E., Friedman, M., Sundström, J., Kockum, I. S., Klareskog, L., Almqvist, C., Bergen, S. E., Czene, K., Hägg, S., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13330 · Cited by 53
Globig, A.-M., Hipp, A. V., Otto-Mora, P., Heeg, M., Mayer, L., Ehl, S. R., Schwacha, H., Bewtra, M., Tomov, V. T., Thimme, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31229-z · Cited by 34
Rise of precision medicine: can it deliver on its promise in IBD?
Schreiber, S., Aden, K., Tran, F., & Rosenstiel, P. C. (2025) · Gut · doi:10.1136/gutjnl-2023-330000 · Cited by 38
Rampal, R., Wari, M. N., Singh, A. K., Das, U., Bopanna, S., Gupta, V., Nayak, B., Velapandian, T., Kedia, S., Kumar, D., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa121 · Cited by 37
Vitamin D increases programmed death receptor-1 expression in Crohn’s disease
Bendix, M., Greisen, S. R., Dige, A. K., Hvas, C. L., Fuglsang, N. F. B., Jørgensen, S. P., Dahlerup, J. F., Deleuran, B. W., & Agnholt, J. S. (2017) · Oncotarget · doi:10.18632/oncotarget.15489 · Cited by 32
Inflammatory bowel disease: long-term therapeutic challenges
Ashton, J. J., Green, Z., Kolimarala, V. K., & Beattie, R. M. (2019) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2019.1685872 · Cited by 33
Yang, H., Li, Y., Shen, S., Gan, D., Han, C., Wu, J., & Wang, Z. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7870424 · Cited by 32
Liu, X., Tang, H., Zhou, Q., Zeng, Y.-L., Chen, D., Xu, H., Li, Y., Tan, B., & Qian, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i2.272 · Cited by 34
Argmann, C., Tokuyama, M. A., Ungaro, R. C., Huang, R., Hou, R., Gurunathan, S. V., Kosoy, R., Narzo, A. D., Wang, W., Losic, B., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.053 · Cited by 31
Exhaustion of CD39-Expressing CD8+ T Cells in Crohn’s Disease Is Linked to Clinical Outcome
Globig, A.-M., Mayer, L., Heeg, M., Andrieux, G., Ku, M., Otto-Mora, P., Hipp, A. V., Zoldan, K., Pattekar, A., Rana, N., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.06.045 · Cited by 32
Ferru-Clément, R., Boucher, G., Forest, A., Bouchard, B., Bitton, A., Lesage, S., Schumm, L. P., Lazarev, M. G., Brant, S. R., Duerr, R. H., et al. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac281 · Cited by 31
Ulcerative Colitis: Current and Future Treatment Strategies
Lissner, D., & Siegmund, B. (2013) · Digestive Diseases · doi:10.1159/000347194 · Cited by 30
STAT signaling as a marker of SLE disease severity and implications for clinical therapy
Goropevšek, A., Holcar, M., Pahor, A., & Avčin, T. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.08.010 · Cited by 31
Schnitzler, F., Friedrich, M., Wolf, C., Angelberger, M., Diegelmann, J., Olszak, T., Beigel, F., Tillack, C., Stallhofer, J., Göke, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108503 · Cited by 29
Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
Flint, S. M., Jovanović, V., Teo, B. W., Mak, A., Thumboo, J., McKinney, E. F., Lee, J. C., MacAry, P. A., Kemeny, D. M., Jayne, D. R. W., et al. (2016) · RMD Open · doi:10.1136/rmdopen-2015-000183 · Cited by 29
Self-citationBourgonje, A. R., van Goor, H., Faber, K. N., & Dijkstra, G. D. H. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000579 · Cited by 31
Choung, R. S., Petralia, F., Torres, J., Ungaro, R. C., Porter, C., Sato, T., Telesco, S., Strauss, R. S., Plevy, S. E., Princen, F., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.01.033 · Cited by 30
Edison, N., Peled, H. B., Eitan, Y., Guthmann, Y., Yeremenko, Y., Raffeld, M. A., Elmalah, I., & Trougouboff, P. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.06.021 · Cited by 28
Dai, S., Gu, H., Lin, Q., Huang, S., Xing, T., Zhang, Q., Wu, G., Chen, M., Tan, W.-E., Hongjian, J., et al. (2017) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2017.03.009 · Cited by 30
Precision medicine and drug optimization in adult inflammatory bowel disease patients
Vieujean, S., & Louis, E. J. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231173331 · Cited by 31
Lopes, P., Afonso, J., Pinto-Lopes, R., Rocha, C., Lago, P. M., Gonçalves, R., de Sousa, H. T., Macedo, G., Dias, C. C., & Magro, F. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz319 · Cited by 29
The Immunogenetics of Autoimmune Cholestasis
Trivedi, P. J., & Hirschfield, G. M. (2015) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.08.002 · Cited by 29
Hou, Y., Wu, J., Wang, M.-Y., Wu, M., Chen, K.-Y., Yeh, S., & Lin, M. (2014) · Mediators of Inflammation · doi:10.1155/2014/837107 · Cited by 26
Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders
Zundler, S., & Neurath, M. F. (2017) · Immunological Reviews · doi:10.1111/imr.12544 · Cited by 34
Can molecular stratification improve the treatment of inflammatory bowel disease?
Wang, C., Baer, H. M., Gaya, D. R., Nibbs, R. J. B., & Milling, S. W. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104442 · Cited by 30
Defining the Path Forward for Biomarkers to Address Unmet Needs in Inflammatory Bowel Diseases
Honig, G., Heller, C. A., & Hurtado‐Lorenzo, A. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa210 · Cited by 26
Factors affecting the accuracy of a class prediction model in gene expression data
Novianti, P. W., Jong, V. L., Roes, K. C. B., & Eijkemans, M. J. C. (2015) · BMC Bioinformatics · doi:10.1186/s12859-015-0610-4 · Cited by 25
Biomarkers of Crohn’s Disease to Support the Development of New Therapeutic Interventions
Porter, A. C., Aubrecht, J., Birch, C., Braun, J. G., Cuff, C. A., Dasgupta, S., Gale, J. D., Hinton, R., Hoffmann, S. C., Honig, G., et al. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa215 · Cited by 24
The challenges of stratifying patients for trials in inflammatory bowel disease
Biancheri, P., Powell, N., Monteleone, G., Lord, G. M., & MacDonald, T. T. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.002 · Cited by 30
Recommendations for identifying Crohn’s disease patients with poor prognosis
Miheller, P., Kiss, L. S., Juhász, M. F., Mandel, M., & Lakatos, P. L. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.12.86 · Cited by 23
Strategies for improving the efficacy and therapeutic ratio of glucocorticoids
Adcock, I. M., Caramori, G., & Kirkham, P. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.006 · Cited by 22
Goropevšek, A., Gorenjak, M., Gradišnik, S., Dai, K., Holc, I., Hojs, R., Krajnc, I., Pahor, A., & Avčin, T. (2017) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2016.0040 · Cited by 22
Precision Medicine in Inflammatory Bowel Diseases
Marafini, I., & Monteleone, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.653924 · Cited by 22
IBD—genes, bacteria and new therapeutic strategies
Colombel, J. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.170 · Cited by 22
Kang, S. J., Kim, J. M., Koh, S., Kim, S. H., Im, J. P., Jung, H. C., & Kim, J. S. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.04.003 · Cited by 24
Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC)
Janmohamed, A., & Trivedi, P. J. (2018) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2018.06.002 · Cited by 21
Potdar, A. A., Li, D., Haritunians, T., VanDussen, K. L., Fiorino, M. F., Liu, T., Stappenbeck, T. S., Fleshner, P. R., Targan, S. R., McGovern, D. P. B., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz021 · Cited by 22
Renegade homeostatic cytokine responses in T1D: Drivers of regulatory/effector T cell imbalance
Gupta, S. S., Cerosaletti, K. M., & Long, S. A. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.02.007 · Cited by 22
The Use of Prognostic Factors in Inflammatory Bowel Diseases
Billiet, T., Ferrante, M., & Assche, G. V. (2014) · Current Gastroenterology Reports · doi:10.1007/s11894-014-0416-y · Cited by 23
Innate immune receptors for cross-presentation: The expanding role of NLRs
Corridoni, D., & Simmons, A. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.11.028 · Cited by 20
Serum N-Glycomic Biomarkers Predict Treatment Escalation in Inflammatory Bowel Disease
Shubhakar, A., Jansen, B. C., Adams, A. T., Reiding, K. R., Ventham, N. T., Kalla, R., Bergemalm, D., Urbanowicz, P. A., Gardner, R. A., Wuhrer, M., et al. (2023) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjad012 · Cited by 20
Therapeutic innovations in inflammatory bowel diseases
Vanhove, W., Nys, K., & Vermeire, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.286 · Cited by 24
Richard, A. C., Peters, J. E., Lee, J. C., Vahedi, G., Schäffer, A. A., Siegel, R. M., Lyons, P. A., & Smith, K. G. C. (2016) · Genome Medicine · doi:10.1186/s13073-016-0329-5 · Cited by 21
Self-citationCandidate Serum Markers in Early Crohn’s Disease: Predictors of Disease Course
Smids, C., Horje, C. S. H. T., Nierkens, S., Drylewicz, J., Groenen, M. J. M., Wahab, P. J., & van Lochem, E. G. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx049 · Cited by 20
Recent advances in inflammatory bowel disease therapy
Binienda, A., Fichna, J., & Sałaga, M. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105550 · Cited by 22
Goropevšek, A., Gorenjak, M., Gradišnik, S., Dai, K., Holc, I., Hojs, R., Krajnc, I., Pahor, A., & Avčin, T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0416-194r · Cited by 20
Kulecka, M., O’Sullivan, J., Fitzgerald, R. S., Velikonja, A., Huseyin, C. E., Mendieta, E. J. L., Ruiz‐Limón, P., Eckenberger, J., Vidal-Marín, M., Truppel, B.-A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62533-z · Cited by 24
Geng, B., Ding, X., Li, X., Liu, H., Zhao, W., Gong, H., Tian, Z., & Guo, J. (2023) · BMC Gastroenterology · doi:10.1186/s12876-023-02769-5 · Cited by 19
Towards a Novel Molecular Classification of IBD
Vermeire, S. (2012) · Digestive Diseases · doi:10.1159/000338147 · Cited by 21
CD8-mediated inflammatory central nervous system disorders
Willing, A., & Friese, M. A. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328352ea8b · Cited by 26
Muraro, D., & Simmons, A. (2016) · BMC Bioinformatics · doi:10.1186/s12859-016-0886-z · Cited by 19
Iliopoulou, L., & Kollias, G. A. (2021) · Mucosal Immunology · doi:10.1038/s41385-021-00433-3 · Cited by 22
Vatn, S., Lindstrøm, J. C., Moen, A. E., Brackmann, S., Tannæs, T. M., Olbjørn, C., Bergemalm, D., Keita, Å. V., Gomollón, F., Detlie, T. E., et al. (2022) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s343468 · Cited by 19
Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation
Wang, Z., Vaughan, T. Y., Zhu, W., Chen, Y., Fu, G., Medrzycki, M., Nishio, H., Bunting, S. T., Hankey-Giblin, P. A., Nusrat, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00486 · Cited by 18
“Human IBD is a complex disorder resulting from the combination of genetic predisposition, environmental triggers, and the loss of integrity of the mucosal immune system.”
BackgroundInfluentialAltered activation of peripheral CD8+ T cells in pediatric Crohn’s disease
Orbán, C., Szabó, D., Bajnok, A., Vásárhelyi, B., Tulassay, T., Arató, A., Veres, G., & Toldi, G. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.03.009 · Cited by 18
Predicting the Course of IBD: Light at the End of the Tunnel?
Lee, J. C. (2012) · Digestive Diseases · doi:10.1159/000341132 · Cited by 18
Self-citationGurram, B., Salzman, N. H., Kaldunski, M. L., Jia, S., Li, B. U. K., Stephens, M. C., Sood, M. R., & Hessner, M. J. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12753 · Cited by 22
Cheah, E., & Huang, J. G. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i10.1539 · Cited by 18
Epigenetic regulation and therapeutic strategies in ulcerative colitis
Yan, L., Gu, C., Gao, S., & Wei, B. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1302886 · Cited by 19
PCSK9 in T-cell function and the immune response
Wang, Y., Fang, X., Liu, J., Lv, X., Lu, K., Lu, Y., & Jiang, Y. (2024) · Biomarker Research · doi:10.1186/s40364-024-00712-8 · Cited by 19
Ceccato, H. D., Silva, T., Genaro, L. M., Silva, J. F., de Souza, W. M., Oliveira, P. D. S. P., de Azevedo, A. T., Ayrizono, M. D. L. S., & Leal, R. F. (2025) · American Journal of Translational Research · doi:10.62347/xill3707 · Cited by 20
A new method of identifying glioblastoma subtypes and creation of corresponding animal models
Zhou, X., Li, G., An, S., Li, W., Yang, H., Guo, Y., Dai, Z., Dai, S., Zheng, J., Huang, J., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0305-1 · Cited by 17
Genetics in Diagnosing and Managing Inflammatory Bowel Disease
McCauley, J. L., & Abreu, M. T. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.01.002 · Cited by 19
Jamwal, D. R., Marati, R., Harrison, C. A., Midura‐Kiela, M. T., Figliuolo, V. R., Besselsen, D. G., Ghishan, F. K., & Kiela, P. R. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz191 · Cited by 16
Schroeter, C. B., Huntemann, N., Böck, S., Nelke, C., Kremer, D., Pfeffer, K., Meuth, S. G., & Ruck, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.747143 · Cited by 16
Prediction of Crohn’s Disease Stricturing Phenotype Using aNOD2-derived Genomic Biomarker
Ashton, J. J., Cheng, G., Stafford, I. S., Kellermann, M., Seaby, E. G., Cummings, F. J. R., Coelho, T. A. F., Batra, A., Afzal, N. A., Beattie, R. M., et al. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac205 · Cited by 19
Wnt5 controls splenic myelopoiesis and neutrophil functional ambivalency during DSS-induced colitis
Luan, Y., Hu, J., Wang, Q., Wang, X., Li, W., Qu, R., Yang, C., Rajendran, B. K., Zhou, H., Liu, P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113934 · Cited by 14
Akkoç, T. (2024) · Tissue Barriers · doi:10.1080/21688370.2024.2390705 · Cited by 17
Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights
Alarfaj, S. J., Mostafa, S. A., Negm, W. A., El-Masry, T. A., Kamal, M., El-Saeed, M., & Nakib, A. M. E. (2023) · Pharmaceuticals · doi:10.3390/ph16020324 · Cited by 17
Ciccocioppo, R., Baumgart, D. C., dos Santos, C. C., Galipeau, J., Klersy, C., & Orlando, G. (2019) · Cytotherapy · doi:10.1016/j.jcyt.2019.05.003 · Cited by 18
Molecular diagnosis: Implications for ophthalmology
Rosenbaum, J. T., Sibley, C. H., Choi, D., Harrington, C. A., & Planck, S. R. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.11.001 · Cited by 14
Li, H., Li, Q., Sun, S., Lei, P., Cai, X., & Shen, G. (2020) · Journal of Immunology Research · doi:10.1155/2020/3067273 · Cited by 15
Predicting outcomes in acute severe ulcerative colitis
Ventham, N. T., Kalla, R., Kennedy, N. A., Satsangi, J., & Arnott, I. D. (2014) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.992880 · Cited by 14
Wang, S., & Qin, C. (2017) · DNA and Cell Biology · doi:10.1089/dna.2016.3570 · Cited by 15
Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics
Stylianou, E. (2017) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-017-0298-4 · Cited by 15
Ma, Y., Chen, B., Xu, X., & Lin, G. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2082-1 · Cited by 15
Haglund, S., Söderman, J., & Almer, S. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065820 · Cited by 13
Uhde, A., Herder, V., Khan, M. A., Ciurkiewicz, M., Schaudien, D., Teich, R., Floess, S., Baumgärtner, W., Huehn, J., & Beineke, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0161883 · Cited by 13
Precision Medicine in Inflammatory Bowel Disease
Annese, V., & Annese, M. (2023) · Diagnostics · doi:10.3390/diagnostics13172797 · Cited by 15
Can We Predict the High-Risk Patient?
Benitez, J.-M., & Louis, E. J. (2014) · Digestive Diseases · doi:10.1159/000358132 · Cited by 12
Altered splicing associated with the pathology of inflammatory bowel disease
Berger, K., Somineni, R. P., Prince, J., Kugathasan, S., & Gibson, G. C. (2021) · Human Genomics · doi:10.1186/s40246-021-00347-y · Cited by 13
UEG Week 2019 Poster Presentations
Jaeger, M.-C., Guiraud, L., Rolland-Fourcade, C., Rolland, C., Belot, A., Sebbag, M., Bermúdez‐Humarán, L. G., Langella, P., Vergnolle, N., & Deraison, C. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619854671 · Cited by 12
Etiology of Ulcerative Colitis
Preda, C.-M., & Istrătescu, D. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106842 · Cited by 11
Dynamic Imaging of IEL-IEC Co-Cultures Allows for Quantification of CD103-Dependent T Cell Migration
Enderle, K., Dinkel, M., Spath, E.-M., Schmid, B., Zundler, S., Tripal, P., Neurath, M. F., Hildner, K., & Neufert, C. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105148 · Cited by 10
Magro, F., Alves, C., Santiago, M., Ministro, P., Lago, P. M., Correia, L., Gonçalves, R., Carvalho, D., Portela, F., Dias, C. C., et al. (2021) · United European Gastroenterology Journal · doi:10.1002/ueg2.12183 · Cited by 9
Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection
Tabbarah, S., Sulaiman, H., Owusu, F. A., Joshi, M. R., Marepalli, N. R., Pino, N., Azam, S. S., Ahmed, A. A., & Álvarez, J. A. S. (2024) · Cureus · doi:10.7759/cureus.70148 · Cited by 14
Prognosis in autoimmune and infectious disease: new insights from genetics
Lee, J. C., & Smith, K. G. C. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.8 · Cited by 9
Self-citationTests that now deserve to be more widely adopted in IBD clinical practice
Labarile, N., Ghosh, S. K., Ng, S. C., Walters, J. R. F., & Iacucci, M. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820944088 · Cited by 9
Metadata
- Authors
- Lee, J. C., Lyons, P. A., McKinney, E. F., Sowerby, J. M., Carr, E. J., Bredin, F., Rickman, H. M., Ratlamwala, H., Hatton, A., Rayner, T. F., Parkes, M., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Smith, Kenneth G.C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-10-03
- Volume
- 121
- Issue
- 10
- Pages
- 4170-4179
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3196314
- OpenAlex
- W2015008025
- Cited by
- 304
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 30 · 2022: 29 · 2021: 27 · 2020: 28 · 2019: 40 · 2018: 10 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 16 · 2012: 17
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 079895/Z/06/Z, 079895, 079895/Z/06/B)
- Crohn's and Colitis UK (M09-2)
- Medical Research Council
- Cambridge Institute for Medical Research, University of Cambridge (079895)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Crohn's disease, ulcerative colitis, inflammatory bowel disease, CD8+ T cells, gene expression profiling, prognostic factors, recurrence, IL-7 signaling, T cell receptor signaling, CD4+ T cells, personalized treatment
- MeSH terms
- Adult, Colitis, Ulcerative, Crohn Disease, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Receptors, Antigen, T-Cell, Signal Transduction, Interleukin-7, CD8-Positive T-Lymphocytes, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.